Categories AlphaGraphs, Earnings, Technology

Garmin reports solid Q2 results; raises outlook

Garmin Ltd. (GRMN) surpassed market expectations on revenue and pro forma EPS numbers for the second quarter of 2018 and raised its outlook for the full year.

The company reported revenues of $894 million for Q2 2018, up 8% compared to the same period last year. Net income was $190.3 million or $1.00 per share compared to $176.9 million or $0.94 per share in the prior-year quarter. Pro forma EPS grew 9% to $0.99.

Garmin second quarter 2018 earnings
Garmin Q2 2018 Earnings Infographic

The fitness, marine, aviation and outdoor segments collectively grew 17% versus the prior-year period and contributed 80% of the total revenue. Revenues in the auto segment declined 19% mainly due to the PND market contraction.

The fitness and marine segments posted double-digit revenue growth helped by strength in advanced wearables and cycling, organic growth across multiple product categories and the Navionics acquisition. Garmin sees opportunities for advanced wearables within fitness and the company is focusing on innovations and gaining market share within the inland fishing category.

During the quarter, Garmin launched the new Panoptix LiveScopeTM, delivering the first and only live scanning sonar for recreational fishing. The company also unveiled the vívoactive 3 music, expanding its music offerings into the advanced wellness category.

Garmin is raising its full-year 2018 guidance based on its performance during the first six months. The company now expects revenues to total approx. $3.3 billion compared to the prior guidance of $3.2 billion. The change in revenue outlook is fueled by higher expectations for the fitness and aviation segments.

Pro forma EPS for 2018 is expected to be approx. $3.30. Gross margin is expected to be 58.5% and operating margin is expected to be 21.5%.

Related: Earnings preview: Has Garmin stayed fit through the second quarter?

Related: Garmin Ltd. Earnings Call Transcript

Related: Garmin Q1 2018 Earnings Infographic

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top